首页 | 本学科首页   官方微博 | 高级检索  
检索        

6%羟已基淀粉130/0.4体外循环预充对心脏手术患儿肝肾功能及凝血功能的影响
引用本文:潘四新,薛玉良,王辉.6%羟已基淀粉130/0.4体外循环预充对心脏手术患儿肝肾功能及凝血功能的影响[J].中国体外循环杂志,2009,7(1):16-19.
作者姓名:潘四新  薛玉良  王辉
作者单位:1. 天津儿童医院麻醉科,天津,300074
2. 泰达国际心血管医院麻醉科,天津,300457
3. 天津医院麻醉科,天津,300000
摘    要:目的探讨6%羟乙基淀粉130/0.4(6%HES130/0.4)体外循环(cardiopulmonary bypass,CPB)预充对心脏手术患儿肝肾功能及凝血功能的影响。方法40例CPB行心脏直视手术的患儿,性别不限,年龄≤6岁,随机分为实验组(6%HES130/0.4预充,n=20)和对照组(血浆预充,n=20)。分别于术前一日(110)及手术结束时即刻(T1)取患儿静脉血2ml分别装入两个试管送生化室检测患儿的丙氨酸氨基转移酶(ALT)、总胆红素(TBIL)、尿素(UREA)、肌酸酐(CREA)、凝血酶原时间(PT)、活化部分凝血活酶时间(APTT)、凝血酶时间(TT)、纤维蛋白原(Fbg)。结果与对照组比较,实验组ALT、TBIL、CREA明显下降(P〈0.05),PT、APTT明显延长且Fbg明显降低(P〈0.05)。结论CPB预充6%HES130/0.4对心脏手术患儿的肝肾功能无损伤,而有保护作用,对凝血功能有影响,但未见临床明显出血。

关 键 词:羟已基淀粉  肝肾功能  凝血功能  体外循环  婴幼儿

The Effects of Using Hydroxyethyl Starch 130/0.4 or Plasma in Cardiopulmonary Bypass Priming solusion on Hepatic-Renal Function and Coagulation
PAN Si-xin,XUE Yu-liang,WANG Hui.The Effects of Using Hydroxyethyl Starch 130/0.4 or Plasma in Cardiopulmonary Bypass Priming solusion on Hepatic-Renal Function and Coagulation[J].Chinese Journal of Extracorporeal Circulation,2009,7(1):16-19.
Authors:PAN Si-xin  XUE Yu-liang  WANG Hui
Institution:( Department of Anesthesiology, 1. Tianfin Children Hospital, Tianjin 300074 ;2. TEDA International Cardiovascular Hospital, Tianjin 300457 ;3. Tianjin Hospital, Tiangjin 300000, China)
Abstract:OBJECTIVE To evaluate the effect of hydroxyethyl starch 130/0.4 (HES) used as priming solution for cardiopulmonary bypass CPB) on hepatic -renal function and coagulation in infants undergoing cardiac surgery. METHODS Forty infants of either sex, aged ≤6yr undergoing cardiac surgery with CPB were randomly divided into 2 groups (n =20 each) : HES group and plasma group. Blood samples were taken from the vein at one day before surgery (TO) and at the end of operation ( T1 ) for ALT, TBIL, UREA, Creatinine ( CREA), PT, APTT, TT, Fbg monitoring. RESULTS The serum ALT, TBIL, CREA levels were significant lower in HES group than in plasma group ( P 〈 0.05 ). The PT, APTT were significant longer and the Fbg were significant lower in HES group than in plasma group( P 〈 0.05 ). CONCLUSION Using HES 130/0.4 as priming fluid for CPB had not side effect on hepatic - renal function and had beneficial effects. HES 130/0.4 had some side effects on coagulation, but did not induce bleeding obviously in clinical.
Keywords:Hetastarch  Hepatic - renal function  Coagulation  Cardiopulmonary bypass  Infant
本文献已被 维普 万方数据 等数据库收录!
设为首页 | 免责声明 | 关于勤云 | 加入收藏

Copyright©北京勤云科技发展有限公司  京ICP备09084417号